Arcataur Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,592
Closed -$313K 102
2025
Q2
$313K Hold
3,592
0.1% 85
2025
Q1
$323K Sell
3,592
-232
-6% -$20.8K 0.11% 84
2024
Q4
$305K Sell
3,824
-20
-0.5% -$1.73K 0.1% 84
2024
Q3
$346K Sell
3,844
-3
-0.1% -$252 0.12% 81
2024
Q2
$303K Sell
3,847
-10
-0.3% -$820 0.11% 84
2024
Q1
$336K Hold
3,857
0.12% 81
2023
Q4
$318K Sell
3,857
-40
-1% -$3.05K 0.12% 78
2023
Q3
$305K Hold
3,897
0.13% 77
2023
Q2
$343K Buy
+3,897
New +$335K 0.14% 74

Other funds holding MDT

Arcataur Capital Management's MDT Position: Q3 2025 in Review

Arcataur Capital Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 3,592 shares — an estimated $313K sold.

Arcataur Capital Management first reported a position in MDT in Q2 2023 and held it in 9 quarters. The position peaked at $346K in Q3 2024. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Arcataur Capital Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Arcataur Capital Management sold 3,592 Medtronic shares in Q3 2025, an estimated $313K.
  • Arcataur Capital Management first reported a position in Medtronic in Q2 2023 and held it in 9 quarters.
  • Arcataur Capital Management's Medtronic position peaked at $346K in Q3 2024.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Arcataur Capital Management's 13F filing for Q3 2025, filed 22 Oct 2025.